ANIX Anixa Biosciences Inc
Company Analysis
Latest News
🟢 Anixa Biosciences is trading 10.06% up today, with no clear catalyst identified
Anixa Biosciences is trading 10.06% up at $3.50, but no clear company-specific catalyst has been identified for August 17, 2026. - CEO Amit Kumar’s purchase...
🟢 Anixa Biosciences is trading 5.6% up today — no clear catalyst identified
Anixa Biosciences is trading 5.6% up now at $3.36, with no clear company-specific catalyst identified for August 17, 2026. - Recent coverage references CEO...
🟢 Anixa Biosciences is trading 6.46% up in after-hours trading with no definitive catalyst identified
Anixa Biosciences is trading at $3.46 (+6.46%) in after-hours trading, with the move appearing speculative or liquidity-driven and no definitive catalyst...
🔴 Anixa Biosciences is trading 12% down today reversing an unexplained pre-market spike
Anixa Biosciences is trading at $3.00 (12% down) as the stock reverses a sharp, largely unexplained pre-market jump seen on August 03, 2026. • The move...
🟢 Anixa Biosciences is trading 13.7% up today despite no clear company-specific catalyst
Anixa Biosciences is trading at $3.89 (+13.74%) in pre-market following a sharp overnight move with no fresh company-specific announcements identified. • The...
🔴 Anixa Biosciences is trading 6.1% down today amid biotech sector weakness
Anixa Biosciences is trading 6.1% down at $3.34 today, giving back a portion of its recent rebound as the broader biotech sector faces selling pressure. • The...
🟢 Anixa Biosciences is trading 6.2% up today amid a broader market rebound
Anixa Biosciences is trading 6.2% up at $3.78 in pre-market, appearing to track a broader risk-on sentiment across U.S. equities. • The move extends a modest...
🟢 Anixa Biosciences up 5.8% as CEO boosts stake and stock rebounds from pullback
• Anixa Biosciences' CEO Amit Kumar made recent significant insider purchases, acquiring thousands of shares on July 27 and July 24. • The stock is rebounding...
🔴 Anixa Biosciences is trading 6.5% down today on profit-taking after recent upgrade-driven rally
Anixa Biosciences is trading 6.5% down today at $3.46 as the stock undergoes consolidation following a significant rally last week. • The recent surge was...
Anixa Biosciences Upgraded to Strong Buy Following Narrower Quarterly Loss
Zacks Research upgraded Anixa Biosciences from a hold to a strong-buy recommendation. The upgrade follows the clinical-stage immuno-oncology company...
🟢 Anixa Biosciences is trading 5.3% up today despite no clear catalyst
Anixa Biosciences is trading 5.3% up at $3.71 despite a lack of fresh company-specific news, regulatory updates, or analyst calls hitting the wires. • The...
🟢 Anixa Biosciences is trading 6.1% up today amid a broader biotech rally and oncology pipeline optimism
Anixa Biosciences is trading 6.1% up at $3.67 today, driven by a broader biotech sector rally and positive sentiment surrounding its oncology pipeline. • The...
🟢 Anixa Biosciences is trading 5.9% up today with no clear company-specific catalyst
Anixa Biosciences is trading at $3.60 (+5.88%) in pre-market following a modest late-week rebound despite a lack of fresh company-specific news. • The upward...
🟢 Anixa Biosciences is trading 6.5% up today as it rebounds from recent biotech sector volatility
Anixa Biosciences is trading at $3.62 (6.5% up) in after-hours, rebounding from recent biotech-sector weakness and volatility earlier this week. • The move...
🔴 Anixa Biosciences is trading 7.6% down today amid broader biotech sector weakness
Anixa Biosciences is trading at $3.14 (7.6% down) in after-hours, reversing its 5.1% regular-session rebound as the broader biotech sector remains under...
🟢 Anixa Biosciences is trading 5.1% up today, rebounding despite a broader biotech sector sell-off
Anixa Biosciences is trading 5.1% up today at $3.49, rebounding from a previous session drop despite a broader market downturn. • The stock is significantly...
🟢 Anixa Biosciences is trading 10.2% up
Anixa Biosciences is trading at $3.66, up 10.2% from a comparison close of $3.32 during pre-market. This is a price-action follow-up, so a separate catalyst...
Anixa's Australian Patent Win Fuels a 19% Weekly Rally — But Can IP Filings Alone Justify the Bet on a Pre-Revenue Cancer Biotech?
Shares of Anixa Biosciences surged 9.6% to $3.64 in pre-market trading, extending a week-long rally of roughly 19% from $3.06 on July 10. The catalyst: IP...
🟢 Anixa Biosciences is trading 9.6% up today after Australian patent acceptance for breast cancer vaccine technology
Anixa Biosciences is trading at $3.64 (+9.64%) after the company announced that IP Australia issued a Notice of Acceptance for a new patent protecting its...
🟢 Anixa Biosciences is trading 5.4% up today after Australian patent acceptance
Anixa Biosciences is trading at $3.50 (+5.42%) following sustained momentum from its Australian patent acceptance for breast cancer vaccine technology. • The...